Comparative Effectiveness of Secukinumab and Golimumab in Ankylosing Spondylitis: Assessed By Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data

被引：0
|
作者：
Maksymowych, Walter P. [1 ]
Choy, Ernest [2 ]
Yazici, Yusuf [3 ]
Walsh, Jessica A. [4 ]
Thom, Howard [5 ]
Kalyvas, Chrysostomos [6 ]
Fox, Todd [7 ]
Gandhi, Kunal [8 ]
Jugl, Steffen [7 ]
机构：
[1] Univ Alberta, Radiol & Diagnost Imaging, Edmonton, AB, Canada
[2] Cardiff Univ, Sect Rheumatol, Cardiff, S Glam, Wales
[3] NYU, Sch Med, New York, NY USA
[4] Univ Utah, Div Rheumatol, Salt Lake City, UT USA
[5] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England
[6] MAPI Grp, Real World Strategy & Analyt, Houten, Netherlands
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1546
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    Rheumatology and Therapy, 2018, 5 : 595 - 595
  • [22] Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Taieb, Vanessa
    Eells, Jason
    McInnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1413 - 1423
  • [23] Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Warren, Richard B.
    Mcinnes, Iain B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mease, Philip J.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 829 - 839
  • [24] Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mcinnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1403 - 1412
  • [25] COMPARATIVE EFFECTIVENESS OF PEGCETACOPLAN VERSUS RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A MATCHING-ADJUSTED INDIRECT COMPARISON USING 26 WEEK PEGASUS PHASE 3 TRIAL DATA
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata
    EXPERIMENTAL HEMATOLOGY, 2021, 100 : S65 - S65
  • [26] SECUKINUMAB SHOWS HIGHER SYMPTOMATIC IMPROVEMENT VERSUS ETANERCEPT IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 24 WEEKS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON
    Mease, P.
    Choy, E.
    Thom, H.
    Kalyvas, C.
    Lopes, N.
    Pricop, L.
    Gandhi, K.
    Jugl, S. M.
    Nash, P.
    VALUE IN HEALTH, 2017, 20 (09) : A936 - A936
  • [27] SECUKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB UP TO 48 WEEKS USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Nash, P.
    McInnes, I. B.
    Mease, P.
    Thom, H.
    Cure, S.
    Palaka, E.
    Gandhi, K.
    Mpofu, S.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 353 - 354
  • [28] Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
    Mahon, Ronan
    Tiwari, Santosh
    Koch, Mirja
    Ferraris, Matias
    Betts, Keith A.
    Wang, Yan
    Gao, Sophie
    Proot, Pascal
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (03)
  • [29] A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM A GERMAN PAYER PERSPECTIVE
    Gunda, P.
    Kandhare, A.
    Nikoglou, E.
    Jugl, S. M.
    Kneidl, J.
    Neidhardt, K.
    VALUE IN HEALTH, 2016, 19 (07) : A537 - A537
  • [30] Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison
    Cohan, S.
    Kumar, J.
    Arndorfer, S.
    Zhu, X.
    Zivkovic, M.
    Tencer, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 140 - 140
12345